Visomitin SkQ1 Drops

Description

The mechanism of action of SkQ1 involves at least two extremely complex and novel concepts: delivering a compound inside mitochondria and reducing ROS production inside mitochondria in a controlled and sustainable manner. SkQ1 molecule successfully addresses these two aspects as experimental work has shown.

More than a dozen studies have been conducted and showed SkQ1 effectiveness in such critical therapeutic areas as the following:

• Age-related macular degeneration (AMD)
• Dry eye syndrome (DES)
• Non-infectious uveitis
• Cataract
• Glaucoma